Skip to main content
Top
Published in: Cancer Causes & Control 12/2012

01-12-2012 | Original Paper

Infectious mononucleosis and risk of breast cancer in a prospective study of women

Authors: J. Massa, A. Hamdan, K. C. Simon, K. Bertrand, G. Wulf, R. M. Tamimi, A. Ascherio

Published in: Cancer Causes & Control | Issue 12/2012

Login to get access

Abstract

Purpose

The association between infectious mononucleosis (IM) and risk of breast cancer is unclear; no prospective studies have examined this relationship. We examined self-reported history and age at IM in relation to risk of invasive breast cancer.

Methods

Self-reported history and age at IM were examined in relation to risk of invasive breast cancer in a large cohort of women, the Nurses’ Health Study II (81,807 women followed from 1989 to 2007). Through questionnaires, women were asked whether they ever had IM and if so, at what age. During follow-up, 2,349 cases of invasive breast cancer were documented. Cox proportional hazards regression was used to estimate relative risks (RR) and 95 % confidence intervals (CI) for the association of IM with breast cancer.

Results

The multivariable-adjusted RR for history of IM and risk of invasive breast cancer was 1.00 (95 % CI: 0.90–1.11). Similar null results were obtained when estrogen receptor/progesterone receptor positive and negative tumors were considered separately. There were no clear patterns of association between age at IM and risk of breast cancer: compared to women with no history of IM, those who were ≤15 years old when they had IM were at lower risk (RR: 0.77; 95 % CI: 0.60, 0.97), but there was no association for women who had IM at ages 16–19, 20–24, or 30+. However, an increased RR (1.45; 95 % CI: 1.02–2.04) was observed for women who had IM at ages 25–29.

Conclusion

Results of this large prospective study do not support a clear association between history of clinical IM and risk of invasive breast cancer.
Literature
3.
go back to reference Amarante MK, Watanabe MA (2009) The possible involvement of virus in breast cancer. J Cancer Res Clin Oncol 135:329–337PubMedCrossRef Amarante MK, Watanabe MA (2009) The possible involvement of virus in breast cancer. J Cancer Res Clin Oncol 135:329–337PubMedCrossRef
4.
go back to reference Mant C, Hodgson S, Hobday R, D’Arrigo C, Cason J (2004) A viral aetiology for breast cancer: time to re-examine the postulate. Intervirology 47:2–13PubMedCrossRef Mant C, Hodgson S, Hobday R, D’Arrigo C, Cason J (2004) A viral aetiology for breast cancer: time to re-examine the postulate. Intervirology 47:2–13PubMedCrossRef
5.
go back to reference Lawson JS, Gunzburg WH, Whitaker NJ (2006) Viruses and human breast cancer. Future Microbiol 1:33–51PubMedCrossRef Lawson JS, Gunzburg WH, Whitaker NJ (2006) Viruses and human breast cancer. Future Microbiol 1:33–51PubMedCrossRef
6.
go back to reference Evans AS (1971) The spectrum of infections with Epstein-Barr virus: a hypothesis. J Infect Dis 124:330–337PubMedCrossRef Evans AS (1971) The spectrum of infections with Epstein-Barr virus: a hypothesis. J Infect Dis 124:330–337PubMedCrossRef
7.
go back to reference Rickinson AB, Kieff E (1996) Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology, 3rd edn. Lippincott-Raven Publishers, Philadelphia, pp 2397–2446 Rickinson AB, Kieff E (1996) Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology, 3rd edn. Lippincott-Raven Publishers, Philadelphia, pp 2397–2446
8.
go back to reference Niederman JC, Evans AS (1997) Epstein-Barr Virus. In: Evans AS, Kaslow RA (eds) Viral infections of humans: epidemiology and control, 4th edn. Plenum Medical Book Company, New York, pp 253–283 Niederman JC, Evans AS (1997) Epstein-Barr Virus. In: Evans AS, Kaslow RA (eds) Viral infections of humans: epidemiology and control, 4th edn. Plenum Medical Book Company, New York, pp 253–283
9.
go back to reference Fleisher GR (1984) Epstein-Barr virus. In: Belshe BB (ed) Textbook of human virology. PSG, Littleton, pp 853–886 Fleisher GR (1984) Epstein-Barr virus. In: Belshe BB (ed) Textbook of human virology. PSG, Littleton, pp 853–886
10.
go back to reference Niedobitek G, Meru N, Delecluse HJ (2001) Epstein-Barr virus infection and human malignancies. Int J Exp Pathol 82:149–170PubMedCrossRef Niedobitek G, Meru N, Delecluse HJ (2001) Epstein-Barr virus infection and human malignancies. Int J Exp Pathol 82:149–170PubMedCrossRef
11.
go back to reference Huo Q, Zhang N, Yang Q (2012) Epstein-Barr virus infection and sporadic breast cancer risk: a meta-analysis. PLoS ONE 7:e31656PubMedCrossRef Huo Q, Zhang N, Yang Q (2012) Epstein-Barr virus infection and sporadic breast cancer risk: a meta-analysis. PLoS ONE 7:e31656PubMedCrossRef
12.
go back to reference Bonnet M, Guinebretiere JM, Kremmer E et al (1999) Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 91:1376–1381PubMedCrossRef Bonnet M, Guinebretiere JM, Kremmer E et al (1999) Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 91:1376–1381PubMedCrossRef
13.
go back to reference Labrecque LG, Barnes DM, Fentiman IS, Griffin BE (1995) Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res 55:39–45PubMed Labrecque LG, Barnes DM, Fentiman IS, Griffin BE (1995) Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res 55:39–45PubMed
14.
go back to reference Herrmann K, Niedobitek G (2003) Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma. Breast Cancer Res 5:R13–R17PubMedCrossRef Herrmann K, Niedobitek G (2003) Lack of evidence for an association of Epstein-Barr virus infection with breast carcinoma. Breast Cancer Res 5:R13–R17PubMedCrossRef
15.
go back to reference Michelow P, Wright C, Pantanowitz L (2012) A review of the cytomorphology of Epstein-Barr virus-associated malignancies. Acta Cytol 56:1–14PubMedCrossRef Michelow P, Wright C, Pantanowitz L (2012) A review of the cytomorphology of Epstein-Barr virus-associated malignancies. Acta Cytol 56:1–14PubMedCrossRef
16.
go back to reference Okano M, Gross TG (2012) Acute or chronic life-threatening diseases associated with Epstein-Barr virus infection. Am J Med Sci 343:483–489PubMedCrossRef Okano M, Gross TG (2012) Acute or chronic life-threatening diseases associated with Epstein-Barr virus infection. Am J Med Sci 343:483–489PubMedCrossRef
17.
go back to reference Yasui Y, Potter JD, Stanford JL et al (2001) Breast cancer risk and “delayed” primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev 10:9–16PubMed Yasui Y, Potter JD, Stanford JL et al (2001) Breast cancer risk and “delayed” primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev 10:9–16PubMed
18.
go back to reference IARC. (1997) Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi’s Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17–24 June 1997. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer. 70:1–492 IARC. (1997) Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi’s Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17–24 June 1997. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer. 70:1–492
19.
go back to reference Gu SY, Huang TM, Ruan L et al (1995) First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen. Dev Biol Stand 84:171–177PubMed Gu SY, Huang TM, Ruan L et al (1995) First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen. Dev Biol Stand 84:171–177PubMed
20.
go back to reference Garland M, Hunter DJ, Colditz GA et al (1999) Alcohol consumption in relation to breast cancer risk in a cohort of United States women 25–42 years of age. Cancer Epidemiol Biomarkers Prev 8:1017–1021PubMed Garland M, Hunter DJ, Colditz GA et al (1999) Alcohol consumption in relation to breast cancer risk in a cohort of United States women 25–42 years of age. Cancer Epidemiol Biomarkers Prev 8:1017–1021PubMed
21.
go back to reference Hernán MA, Zhang SM, Lipworth L, Olek MJ, Ascherio A (2001) Multiple sclerosis and age at infection with common viruses. Epidemiology 12:301–306PubMedCrossRef Hernán MA, Zhang SM, Lipworth L, Olek MJ, Ascherio A (2001) Multiple sclerosis and age at infection with common viruses. Epidemiology 12:301–306PubMedCrossRef
22.
go back to reference Nielsen TR, Rostgaard K, Nielsen NM et al (2007) Multiple sclerosis after infectious mononucleosis. Arch Neurol 64:72–75PubMedCrossRef Nielsen TR, Rostgaard K, Nielsen NM et al (2007) Multiple sclerosis after infectious mononucleosis. Arch Neurol 64:72–75PubMedCrossRef
Metadata
Title
Infectious mononucleosis and risk of breast cancer in a prospective study of women
Authors
J. Massa
A. Hamdan
K. C. Simon
K. Bertrand
G. Wulf
R. M. Tamimi
A. Ascherio
Publication date
01-12-2012
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 12/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0064-1

Other articles of this Issue 12/2012

Cancer Causes & Control 12/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine